Efficiently create and manage cases, streamline workflows, securely store and share documents, and collaborate with colleagues.
Cruxi
FreeStarting price
9.2KMonthly visits
16Popularity
About Cruxi
Cruxi is an AI-powered regulatory submission platform designed for medical device teams. It automates FDA 510(k), De Novo, PMA, IDE, and global filings by leveraging AI-driven device classification, predicate finding, and eSTAR drafting. The platform performs automated RTA (Refusal to Accept) compliance checks, evidence planning, and package export while incorporating human-in-the-loop review to ensure accuracy. Cruxi’s models are trained on FDA guidance and regulatory databases, providing traceable citations with zero-hallucination claims. It offers continuous regulatory updates and enterprise-grade security to help teams accelerate submissions, reduce refusal-to-accept risks, and produce reviewer-ready dossiers. The platform is tailored for medical device manufacturers, regulatory affairs professionals, and compliance teams seeking efficient and compliant submission processes.
Key features
- AI-driven device classification and predicate finding
- Automated eSTAR drafting for FDA submissions
- Real-time RTA compliance checks
- Evidence planning and package export
- Human-in-the-loop review for accuracy
- Traceable citations with zero-hallucination claims
- Continuous regulatory updates
- Enterprise-grade security
- Support for FDA 510(k), De Novo, PMA, IDE, and global filings
- Reviewer-ready dossier generation
Use cases
- Preparing FDA 510(k) submissions for medical devices
- Streamlining De Novo and PMA filings with compliance checks
- Managing global regulatory submissions with automated workflows
Pros
- AI-powered device classification and predicate finding for accurate regulatory pathway identification
- Automated Refusal to Accept (RTA) compliance checks to reduce submission risks
- Supports multiple regulatory pathways including FDA 510(k), De Novo, PMA, IDE, and global filings
- Provides traceable citations with zero-hallucination claims through FDA guidance-trained models
- Offers expert guidance and human-in-the-loop review for submission accuracy
Cons
- May require initial technical adjustments during onboarding for some users
- Dependent on regulatory updates, which may necessitate periodic retraining of AI models
Frequently asked questions about Cruxi
What regulatory pathways does Cruxi support?
Cruxi supports FDA 510(k), De Novo, PMA, IDE, Q-Submission, 513(g), PMA Supplements, HDE, Breakthrough Device Designation, Safer Technologies Program, CLIA Waiver, EU MDR, UKCA, Health Canada MDL, and Australia TGA pathways.
Who is Cruxi designed for?
The platform is tailored for medical device manufacturers, regulatory affairs professionals, and compliance teams seeking efficient and compliant submission processes.
Does Cruxi offer any expert support?
Yes, Cruxi provides expert guidance at every step of the submission journey and connects users with verified regulatory consultants and service providers.
How does Cruxi ensure submission accuracy?
Every submission undergoes automated compliance checks, multi-layer validation, and human-in-the-loop review to ensure alignment with FDA expectations and regulatory precedent.
Can Cruxi help with global regulatory submissions?
Yes, Cruxi supports global regulatory services including EU MDR, UKCA, Health Canada MDL, and Australia TGA submissions.
What is Cruxi's pricing model?
Cruxi offers a platform with AI-powered workflows and expert guidance, with access to regulatory directories and service providers; specific pricing details are available upon request.
Cruxi Website Engagement
Last Update: 9 days ago
Total Monthly Visits
0
Bounce Rate
0%
Visit Duration (avg)
0.00s
Pages Per Visit
0
Country Rank
0
United States
Global Rank
0
Monthly Traffic
Traffic Sources
Traffic Share By Country
- United States43%
- United Kingdom18.4%
- Germany15.9%
- India12.4%
- Turkey10.4%
